Innate Pharma S.A. (FRA:IDD)
1.654
-0.042 (-2.48%)
At close: Dec 5, 2025
Innate Pharma Market Cap
Innate Pharma has a market cap or net worth of €154.10 million as of December 5, 2025. Its market cap has increased by 34.44% in one year.
Market Cap
154.10M
Enterprise Value
121.11M
Revenue
12.64M
Ranking
n/a
PE Ratio
n/a
Stock Price
€1.65
Market Cap Chart
Since November 1, 2006, Innate Pharma's market cap has increased from 792.12K to 154.10M, an increase of 19,354.51%. That is a compound annual growth rate of 31.77%.
Market Cap History
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| SAP SE | 240.49B |
| Siemens Aktiengesellschaft | 177.09B |
| Allianz SE | 138.86B |
| Deutsche Telekom AG | 129.48B |
| Siemens Energy AG | 97.17B |
| Rheinmetall AG | 69.69B |
| Münchener Rückversicherungs-Gesellschaft Aktiengesellschaft in München | 68.36B |
| Deutsche Bank Aktiengesellschaft | 58.36B |